Amedisys, Inc. · Baton Rouge, LA United States (NASDAQ: AMED)
Key Amedisys, Inc. Financials
| Company Type | Public -(NASDAQ: AMED) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $1,634.3 |
| 2010 Employees | 16,300 |
Amedisys, Inc. Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 1,634.3 | 1,513.5 | 1,187.4 |
| Cost of Goods Sold | 820.5 | 724.5 | 562.6 |
| Gross Profit | 813.9 | 789.0 | 624.8 |
| Gross Profit Margin | 49.8% | 52.1% | 52.6% |
| SG&A Expense | 566.5 | 509.8 | 423.3 |
| Depreciation & Amortization | 34.6 | 28.3 | 20.4 |
| Operating Income | 193.5 | 230.7 | 157.1 |
| Operating Margin | 11.8% | 15.2% | 13.2% |
| Nonoperating Income | 0.8 | 3.1 | (0.1) |
| Nonoperating Expenses | (8.8) | (11.5) | (15.6) |
| Income Before Taxes | 185.6 | 222.4 | 141.4 |
| Income Taxes | 72.3 | 86.2 | 54.7 |
| Net Income After Taxes | 113.3 | 136.2 | 86.6 |
| Continuing Operations | 112.6 | 135.8 | 86.7 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 112.6 | 135.8 | 86.7 |
| Total Net Income | 112.6 | 135.8 | 86.7 |
| Net Profit Margin | 6.9% | 9% | 7.3% |
| Diluted EPS from Total Net Income | 3.95 | 4.89 | 3.22 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Amedisys, Inc. Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 120.3 | 34.5 | 2.8 |
| Net Receivables | 141.5 | 150.3 | 175.7 |
| Inventories | -- | -- | -- |
| Other Current Assets | 32.1 | 33.3 | 15.8 |
| Total Current Assets | 293.9 | 218.0 | 194.4 |
| Net Fixed Assets | 138.6 | 91.9 | 79.3 |
| Other Noncurrent Assets | 867.3 | 862.4 | 796.6 |
| Total Assets | 1,299.8 | 1,172.4 | 1,070.2 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 23.4 | 16.5 | 18.7 |
| Short-Term Debt | 37.2 | 44.3 | 42.6 |
| Other Current Liabilities | 155.8 | 168.5 | 143.3 |
| Total Current Liabilities | 216.3 | 229.3 | 204.6 |
| Long-Term Debt | 144.7 | 170.9 | 285.9 |
| Other Noncurrent Liabilities | 61.0 | 37.0 | 18.3 |
| Total Liabilities | 422.0 | 437.2 | 508.9 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | 877.9 | 735.2 | 561.3 |
| Total Equity | 877.9 | 735.2 | 561.3 |
| Shares Outstanding (thou.) | 29,232.8 | 28,191.2 | 26,993.5 |
All amounts in millions of US Dollars except per share amounts.
Amedisys, Inc. Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 206 | 248 | 151 |
| Net Investing Cash Flow | (73.6) | (97.3) | (505.7) |
| Net Financing Cash Flow | (46.8) | (118.8) | 301.6 |
| Net Change in Cash | 85.8 | 31.6 | (53.3) |
| Depreciation & Amortization | 34.6 | 28.3 | 20.4 |
| Capital Expenditures | (66.3) | (41.6) | (33.1) |
| Cash Dividends Paid | (0.3) |
All amounts in millions of US Dollars except per share amounts.